Olivares-Hernández, A.; Figuero-Pérez, L.; Miramontes-González, J.P.; López-Gutiérrez, Á.; González-Sarmiento, R.; Cruz-Hernández, J.J.; Fonseca-Sánchez, E.
Immune System Disorders, Cancer and Viral Infections: A New Treatment Opportunity for the Immune Checkpoint Inhibitors. Life 2021, 11, 1400.
https://doi.org/10.3390/life11121400
AMA Style
Olivares-Hernández A, Figuero-Pérez L, Miramontes-González JP, López-Gutiérrez Á, González-Sarmiento R, Cruz-Hernández JJ, Fonseca-Sánchez E.
Immune System Disorders, Cancer and Viral Infections: A New Treatment Opportunity for the Immune Checkpoint Inhibitors. Life. 2021; 11(12):1400.
https://doi.org/10.3390/life11121400
Chicago/Turabian Style
Olivares-Hernández, Alejandro, Luis Figuero-Pérez, José Pablo Miramontes-González, Álvaro López-Gutiérrez, Rogelio González-Sarmiento, Juan Jesús Cruz-Hernández, and Emilio Fonseca-Sánchez.
2021. "Immune System Disorders, Cancer and Viral Infections: A New Treatment Opportunity for the Immune Checkpoint Inhibitors" Life 11, no. 12: 1400.
https://doi.org/10.3390/life11121400
APA Style
Olivares-Hernández, A., Figuero-Pérez, L., Miramontes-González, J. P., López-Gutiérrez, Á., González-Sarmiento, R., Cruz-Hernández, J. J., & Fonseca-Sánchez, E.
(2021). Immune System Disorders, Cancer and Viral Infections: A New Treatment Opportunity for the Immune Checkpoint Inhibitors. Life, 11(12), 1400.
https://doi.org/10.3390/life11121400
